These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30818852)

  • 1. Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons.
    Donate-Correa J; Tagua VG; Ferri C; Martín-Núñez E; Hernández-Carballo C; Ureña-Torres P; Ruiz-Ortega M; Ortiz A; Mora-Fernández C; Navarro-González JF
    J Clin Med; 2019 Feb; 8(3):. PubMed ID: 30818852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease.
    Donate-Correa J; Sanchez-Niño MD; González-Luis A; Ferri C; Martín-Olivera A; Martín-Núñez E; Fernandez-Fernandez B; Tagua VG; Mora-Fernández C; Ortiz A; Navarro-González JF
    Clin Kidney J; 2022 Dec; 15(12):2200-2213. PubMed ID: 36381364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.
    Navarro-González JF; Sánchez-Niño MD; Donate-Correa J; Martín-Núñez E; Ferri C; Pérez-Delgado N; Górriz JL; Martínez-Castelao A; Ortiz A; Mora-Fernández C
    Diabetes Care; 2018 Aug; 41(8):1817-1820. PubMed ID: 29866645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications.
    Donate-Correa J; Ferri CM; Sánchez-Quintana F; Pérez-Castro A; González-Luis A; Martín-Núñez E; Mora-Fernández C; Navarro-González JF
    Front Med (Lausanne); 2020; 7():628289. PubMed ID: 33553221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline for Diabetic Nephropathy: an Important Opportunity to Re-purpose an Old Drug?
    Bhanot S; Leehey DJ
    Curr Hypertens Rep; 2016 Jan; 18(1):8. PubMed ID: 26747265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.
    Navarro-González JF; Muros M; Mora-Fernández C; Herrera H; Meneses B; García J
    J Diabetes Complications; 2011; 25(5):314-9. PubMed ID: 21144773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pentoxifylline on microalbuminuria in diabetic patients: a randomized controlled trial.
    Shahidi S; Hoseinbalam M; Iraj B; Akbari M
    Int J Nephrol; 2015; 2015():259592. PubMed ID: 25874129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
    Rodríguez-Morán M; Guerrero-Romero F
    Curr Diabetes Rev; 2008 Feb; 4(1):55-62. PubMed ID: 18220696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.
    Chen YM; Chiang WC; Lin SL; Tsai TJ
    J Biomed Sci; 2017 Nov; 24(1):84. PubMed ID: 29132351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renoprotective potential of pentoxifylline in chronic kidney disease.
    Lin SL; Chiang WC; Chen YM; Lai CF; Tsai TJ; Hsieh BS
    J Chin Med Assoc; 2005 Mar; 68(3):99-105. PubMed ID: 15813241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria.
    Badri S; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi M
    J Pharm Pharm Sci; 2011; 14(1):128-37. PubMed ID: 21501559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial.
    de Morales AM; Goicoechea M; Verde E; Carbayo J; Barbieri D; Delgado A; Verdalles U; de Jose AP; Luño J
    J Nephrol; 2019 Aug; 32(4):581-587. PubMed ID: 30949987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline: a potential therapy for chronic kidney disease.
    Lin SL; Chen YM; Chiang WC; Tsai TJ; Chen WY
    Nephrology (Carlton); 2004 Aug; 9(4):198-204. PubMed ID: 15363050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis.
    Leporini C; Pisano A; Russo E; D Arrigo G; de Sarro G; Coppolino G; Bolignano D
    Pharmacol Res; 2016 May; 107():315-332. PubMed ID: 26995301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pentoxifylline on diabetic renal changes in streptozotocin-induced diabetes mellitus.
    Gunduz Z; Canoz O; Per H; Dusunsel R; Poyrazoglu MH; Tez C; Saraymen R
    Ren Fail; 2004 Nov; 26(6):597-605. PubMed ID: 15600249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Effect of Folic Acid and Pentoxifylline on Delaying Dialysis Initiation in Patients with Advanced Chronic Kidney Disease.
    Yang H; Juang SY; Liao KF; Chen YH
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31547288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.